-
A total of 215 providers participated in the 2003 Contraceptive Technology Update Contraception Survey, which monitors contraceptive trends and family planning issues among readers.
-
When discussing contraceptive options with your female patients, what choices are available at your facility? If they include the contraceptive patch (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) and the contraceptive vaginal ring (NuvaRing, Organon, West Orange, NJ), you join the majority of respondents to the 2003 Contraceptive Technology Update Contraception Survey.
-
-
-
While new birth control methods are attracting attention from new and established contraceptive users, family planning clinicians say many women continue to choose combined oral contraceptives (OCs) for safe, reliable pregnancy prevention.
-
Get ready for a major change to occur in the way birth control pills are prescribed and used with the arrival of Seasonale, the first dedicated extended-regimen oral contraceptive.
-
As pointed out in previous OB/GYN Clinical Alerts, about 1 in 4 patients in the United States are delivered by cesarean section, a procedure still classified as a major operation.
-
The Womens Health Initiative (WHI) reports that estrogen-progestin therapy reduces fractures, but the number of gynecologic cancers observed precludes a definitive statement on the risk of endometrial and ovarian cancers.
-
-
Weekly injections of alpha-hydroxyprogesterone caproate resulted in a substantial reduction in the rate of recurrent preterm delivery among women who were at particularly high risk for preterm delivery and reduced the likelihood of several complications in their infants.